APOE*3LEIDEN.CETP TRANSGENIC MICE AS MODEL FOR THE METABOLIC SYNDROME

被引：0
|
作者：
van den Hoek, A. M. [1 ,2 ]
van der Hoorn, J. W. A. [1 ,2 ]
Maas, M. C. E. [1 ]
van den Hoogen, C. M. [1 ]
van Nieuwkoop, A. [1 ]
Offerman, E. O. [1 ]
Pieterman, E. J. [1 ]
Havekes, L. M. [1 ,2 ]
Princen, H. M. G. [1 ]
机构：
[1] TNO Metab Hlth Res, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2011年 / 12卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(11)70245-8
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
244
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [41] Resveratrol Protects Against Atherosclerosis Development in APOE☆3-Leiden.CETP Mice
    Berbee, Jimmy F.
    Wong, Man-Chi
    Wang, Yanang
    Van der Hoorn, Jose W.
    Romijn, Johannes A.
    Havekes, Louis M.
    Princen, Hans M.
    Rensen, Patrick C.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E42 - E43
  • [42] RESVERATROL PROTECTS AGAINST ATHEROSCLEROSIS DEVELOPMENT IN APOE*3-LEIDEN-CETP MICE
    Berbee, J.
    Wong, M. -C.
    Wang, Y.
    van der Hoorn, J.
    Romijn, H.
    Havekes, L.
    Princen, H.
    Rensen, P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 22 - 22
  • [43] RESVERATROL PROTECTS AGAINST ATHEROSCLEROSIS DEVELOPMENT IN APOE*3-LEIDEN.CETP MICE
    Berbee, J.
    Wong, M-C
    Wang, Y.
    van der Hoorn, J.
    Romijn, J.
    Havekes, L.
    Princen, H.
    Rensen, P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [44] PCSK-9 Monoclonal Antibody Alirocumab Dose-Dependently Decreases Atherosclerosis Development and Enhances the Effects of Atorvastatin in APOE*3Leiden.CETP Mice
    Kuhnast, Susan
    van der Hoorn, Jose W.
    Pieterman, Elsbet
    Sasiela, William J.
    Gusarova, Viktoria
    Peyman, Anusch
    Schaefer, Hans-Ludwig
    Schwahn, Uwe
    Jukema, J. Wouter
    Princen, Hans M.
    CIRCULATION, 2013, 128 (22)
  • [45] Body weight-dependent and independent improvement in lipid metabolism after Roux-en-Y gastric bypass in ApoE*3Leiden.CETP mice
    Tarasco, Erika
    Boyle, Christina N.
    Pellegrini, Giovanni
    Arnold, Myrtha
    Steiner, Regula
    Hornemann, Thorsten
    Nasias, Dimitris
    Kardassis, Dimitris
    Whiting, Lynda
    Lutz, Thomas A.
    INTERNATIONAL JOURNAL OF OBESITY, 2019, 43 (12) : 2394 - 2406
  • [46] The metabolism of VLDL remnants in ApoE*3-Leiden transgenic mice
    Havekes, LM
    vanVlijmen, BJM
    Jong, MC
    Groot, PHE
    Frants, RR
    Hofker, MH
    DRUGS AFFECTING LIPID METABOLISM: RISK FACTORS AND FUTURE DIRECTIONS, 1996, 10 : 263 - 270
  • [47] Cholesterol-lowering effect of metformin in the mouse APOE*3-Leiden. CETP, a transgenic model with humanized lipoprotein profile
    Geerling, J.
    van der Zon, G.
    Princen, H.
    Havekes, L.
    Rensen, P.
    Guigas, B.
    DIABETES & METABOLISM, 2011, 37 : A77 - A77
  • [48] A Systems Analysis of Phenotype Heterogeneity in APOE*3Leiden.CETP Mice Induced by Long-Term High-Fat High-Cholesterol Diet Feeding
    Paalvast, Yared
    Zhou, Enchen
    Rozendaal, Yvonne J. W.
    Wang, Yanan
    Gerding, Albert
    van Dijk, Theo H.
    de Boer, Jan Freark
    Rensen, Patrick C. N.
    van Dijk, Ko Willems
    Kuivenhoven, Jan A.
    Bakker, Barbara M.
    van Riel, Natal A. W.
    Groen, Albert K.
    NUTRIENTS, 2022, 14 (22)
  • [49] Dose Effects of Ammonium Perfluorooctanoate on Lipoprotein Metabolism in APOE*3-Leiden.CETP Mice
    Pouwer, Marianne G.
    Pieterman, Elsbet J.
    Chang, Shu-Ching
    Olsen, Geary W.
    Caspers, Martien P. M.
    Verschuren, Lars
    Jukema, J. Wouter
    Princen, Hans M. G.
    TOXICOLOGICAL SCIENCES, 2019, 168 (02) : 519 - 534
  • [50] PXR agonism decreases plasma HDL levels in ApoE*3-Leiden.CETP mice
    de Haan, Willeke
    de Vries-van der Weij, Jitske
    Mol, Isabel M.
    Hoekstra, Menno
    Romijn, Johannes A.
    Jukema, J. Wouter
    Havekes, Louis M.
    Princen, Hans M. G.
    Rensen, Patrick C. N.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2009, 1791 (03): : 191 - 197
12345